Here is my first analysis of the new @IHU_Marseille preprint called 'Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 Outpatients: A Monocentric Retrospective Cohort Study'
Found here: (not sure why in April 2020 folder).
https://mediterranee-infection.com/wp-content/uploads/2020/04/MS-IHU-Preprint.pdf …
-
-
The controls in the study are insufficient for any meaningful conclusions. They clearly have access to comorbidity and other data (they calculated CCI/NEWS-2 scores for some patients) so it's weird they didn't uses these
-
The exclusions are bizarre. They excluded patients who were "cured" - what does this mean? Asymptomatic at presentation? Negative PCR? The supplementary file also says those who refused use of data were excluded but there's no mention of this in the main methodspic.twitter.com/UjEZZMWY5q
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.